ConductScience.org, home

Paper39809756

Digestive cancers: mechanisms, therapeutics and management.

Zhan T and 9 others. Signal Transduct Target Ther, 2025. Cited by 64 papers, by iCite.

Cite this record

ConductScience Library. Digestive cancers: mechanisms, therapeutics and management. Papers, record 39809756. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39809756

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Digestive cancers: mechanisms, therapeutics and management.
PubMed
Journal
Signal Transduct Target Ther
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
64
iCite
Relative citation ratio, by iCite
16.6, provisional
iCite
Revised in PubMed
2026-09-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhan TTianzuo
2Betge JJohannes
3Schulte NNadine
4Dreikhausen LLena
5Hirth MMichael
6Li MMoying
7Weidner PPhilip
8Leipertz AAntonia
9Teufel AAndreas
10Ebert MPMatthias P

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Digestive System NeoplasmsMajor topic
Humans
Immunotherapy

References543

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120728210
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Lancet2010https://conductscience.org/library/papers/20728210PubMed
237731056Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.Oncogene2023https://conductscience.org/library/papers/37731056PubMed
327907852The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials.Eur J Cancer2017https://conductscience.org/library/papers/27907852PubMed
438664720Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study.BMC Cancer2024https://conductscience.org/library/papers/38664720PubMed
526371427Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization.Appl Immunohistochem Mol Morphol2017https://conductscience.org/library/papers/26371427PubMed
614534886Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.Cancer2003https://conductscience.org/library/papers/14534886PubMed
724185513Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers.Nat Genet2013https://conductscience.org/library/papers/24185513PubMed
825712293HER2 expression status in diverse cancers: review of results from 37,992 patients.Cancer Metastasis Rev2015https://conductscience.org/library/papers/25712293PubMed
934258720Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival.Ann Surg Oncol2021https://conductscience.org/library/papers/34258720PubMed
1018650514Sorafenib in advanced hepatocellular carcinoma.N Engl J Med2008https://conductscience.org/library/papers/18650514PubMed
1130070719CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma.Hepatology2019https://conductscience.org/library/papers/30070719PubMed
1237872225CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial.Nat Med2023https://conductscience.org/library/papers/37872225PubMed
1338871975Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.Nat Med2024https://conductscience.org/library/papers/38871975PubMed
1432152502Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer.Br J Cancer2020https://conductscience.org/library/papers/32152502PubMed
1529480368The Global Epidemic of the Metabolic Syndrome.Curr Hypertens Rep2018https://conductscience.org/library/papers/29480368PubMed
1626258846Genomic spectra of biliary tract cancer.Nat Genet2015https://conductscience.org/library/papers/26258846PubMed
1727435280
ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).
BMC Cancer2016https://conductscience.org/library/papers/27435280PubMed
1817470860
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.
J Clin Oncol2007https://conductscience.org/library/papers/17470860PubMed
1927899187Genetic predisposition to gastric cancer.Semin Oncol2016https://conductscience.org/library/papers/27899187PubMed
2034536299Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials.Int J Cancer2022https://conductscience.org/library/papers/34536299PubMed

See all 543 referencesDownload CSV of references

Cited by51

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.

PMIDTitleJournalYearIn PapersSource
42955452Oxeiptosis in gastrointestinal cancer: molecular mechanisms, therapeutic strategies, and future perspectives.Mol Biol Rep2026https://conductscience.org/library/papers/42955452PubMed
42949869Challenges and recommendations for implementation of oncology clinical practice guidelines in China.PLoS Med2026https://conductscience.org/library/papers/42949869PubMed
42830923CPT-TCPP polymeric nanoplatform for sonodynamic-chemotherapy synergistic tumor therapy through ferroptosis-apoptosis dual cell death reprogramming.Mater Today Bio2026https://conductscience.org/library/papers/42830923PubMed
42773444Targeting the Notch signaling pathway in digestive system cancers: from bench to bedside.Cancer Cell Int2026https://conductscience.org/library/papers/42773444PubMed
42750951ANP32A interacts with LDHA to modulate glycolysis and ferroptosis in hepatocellular carcinoma.Front Oncol2026https://conductscience.org/library/papers/42750951PubMed
42683405CD86-Positive Mature Tertiary Lymphoid Structures Are Associated With CD8+ T-Cell Infiltration and Favorable Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.Ann Gastroenterol Surg2026https://conductscience.org/library/papers/42683405PubMed
42661227Dual-energy CT extracellular volume fraction for predicting the chemotherapeutic response in pancreatic ductal adenocarcinoma.Cancer Imaging2026https://conductscience.org/library/papers/42661227PubMed
42649986Biological and Targeted Therapies in the Multidisciplinary Management of Gastrointestinal Cancers.Cancers (Basel)2026https://conductscience.org/library/papers/42649986PubMed
42624930Pharmacological inhibition of CDK7 and CDK9 suppresses gastrointestinal (colon) cancer progression through modulation of stemness, epithelial-mesenchymal transition, and chemoresistance.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42624930PubMed
42597867LncRNA FAM66C enhances gastric cancer proliferation and chemoresistance through phosphorylating nuclear YAP protein.Front Pharmacol2026https://conductscience.org/library/papers/42597867PubMed
42516142Trends in liver failure-related mortality among middle-aged and older adults with digestive system malignant tumors in the United States, 1999-2023.Front Oncol2026https://conductscience.org/library/papers/42516142PubMed
42458480Harnessing tumor-associated exosomal aminopeptidase N as a dual-function tool for monitoring and tackling chemoresistance in gastric cancer.Cell Commun Signal2026https://conductscience.org/library/papers/42458480PubMed
42415117Targeting HASPIN-mediated H3T3 phosphorylation disrupts an epigenetic-kinesin axis to suppress colorectal cancer mitotic progression.Mol Cancer2026https://conductscience.org/library/papers/42415117PubMed
42357585Plant-Derived Foods and Medicines as Modulators of the Gut Microbiome: Molecular Interactions and Implications for Disease and Therapy.Molecules2026https://conductscience.org/library/papers/42357585PubMed
42352257Aloperine Suppresses the Tumorigenicity of Esophageal Squamous Cell Carcinoma by Targeting the AP-1/IL-6/STAT3 Signaling Axis.Biomolecules2026https://conductscience.org/library/papers/42352257PubMed
42327781CDK4/6-targeted therapy for gastrointestinal cancers: from resistance mechanisms to immuno-combination strategies guided by biomarkers.Front Immunol2026https://conductscience.org/library/papers/42327781PubMed
42323891Significance of Positive Cerebrospinal Fluid Cytology (Leptomeningeal Metastasis) in Central Nervous System Metastasis - A Multicentre Clinicopathological Review.Pathol Int2026https://conductscience.org/library/papers/42323891PubMed
42305470Predictive modelling of duodenal stump leakage after gastric cancer and long-term oncological outcomes.Transl Cancer Res2026https://conductscience.org/library/papers/42305470PubMed
42298691Analysis and validation of abnormal signaling pathways and immune cell infiltration characteristics in digestive system cancers based on peroxisome-related genes.Biol Direct2026https://conductscience.org/library/papers/42298691PubMed
42278660Novel Disease-Specific Panel of Salivary microRNAs for the Detection of Oral Squamous Cell Carcinoma from Early Invasion to Stage IV Disease.Int J Mol Sci2026https://conductscience.org/library/papers/42278660PubMed

See all 51 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39809756

GET https://conductscience.org/api/papers/v1/39809756/references?page=2